In Italy, acetylcholinesterase inhibitors (AChEIs) (i.e. donepezil, rivastigmine and galantamine) and memantine (NMDA receptor antagonist) are the approved drugs for treating Alzheimer’s disease (ADDs) and are reimbursed by the Italian NHS. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.